Cagent Vascular Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
78
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$41M
- Investors
-
11
Cagent Vascular General Information
Description
Developer of an intravascular technology designed to treat diseased peripheral arteries. The company's technology is a minimally invasive device for vessel dilatation in cardiovascular disease interventions with multiple longitudinal lines of interrupted micro-serrations used for arterial expansion along those lines, enabling healthcare providers to improve the lives of patients.
Contact Information
Website
www.cagentvascular.comCorporate Office
- 150 Strafford Avenue
- Suite 315
- Wayne, PA 19087
- United States
Corporate Office
- 150 Strafford Avenue
- Suite 315
- Wayne, PA 19087
- United States
Cagent Vascular Timeline
Cagent Vascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series D) | 18-May-2026 | $41M | Completed | Generating Revenue | ||
| 8. Debt - General | 15-Jan-2026 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 20-Feb-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series C) | 30-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 23-Jun-2021 | Completed | Generating Revenue | |||
| 4. Debt - PPP | 29-Apr-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 14-May-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 22-Jun-2016 | $750K | $800K | Completed | Startup | |
| 1. Angel (individual) | 23-Jun-2014 | $50K | $50K | Completed | Startup |
Cagent Vascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C-2 | ||||||||
| Series C-1 | ||||||||
| Series B | 28,527,570 | $0.000010 | $1.25 | $1.25 | 1x | $1.25 | 4.51% | |
| Series A | 7,045,716 | $0.000010 | $1 | $1 | 1x | $1 | 1.11% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cagent Vascular Comparisons
Industry
Financing
Details
Cagent Vascular Competitors (27)
One of Cagent Vascular’s 27 competitors is Wallaby Medical, a Venture Capital-Backed company based in Shanghai, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wallaby Medical | Venture Capital-Backed | Shanghai, China | ||||
| Mercator MedSystems | Venture Capital-Backed | San Leandro, CA | ||||
| Arsenal Medical | Venture Capital-Backed | Waltham, MA | ||||
| Vesper Medical | Formerly VC-backed | Wayne, PA | ||||
| Elixir Medical | Venture Capital-Backed | Milpitas, CA |
Cagent Vascular Patents
Cagent Vascular Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260345180-A1 | Pulse enhanced balloon catheter and methods of use | Pending | 30-Apr-2025 | ||
| US-20260345181-A1 | Pulse enhanced balloon catheter and methods of use | Pending | 30-Apr-2025 | ||
| US-20260345182-A1 | Pulse enhanced balloon catheter and methods of use | Pending | 30-Apr-2025 | ||
| US-20260345183-A1 | Pulse enhanced balloon catheter and methods of use | Pending | 30-Apr-2025 | ||
| US-20260345184-A1 | Pulse enhanced balloon catheter and methods of use | Pending | 30-Apr-2025 | A61B17/2202 |
Cagent Vascular Signals
Cagent Vascular Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Astoria Health Investors | Venture Capital | Minority | ||
| BF Belmont | Family Office | Minority | ||
| Trinity Capital (Phoenix) | Asset Manager | Minority | ||
| Blue Ridge Medical. | Corporation | Minority | ||
| The FSB Companies | PE/Buyout | Minority |
Cagent Vascular FAQs
-
When was Cagent Vascular founded?
Cagent Vascular was founded in 2014.
-
Where is Cagent Vascular headquartered?
Cagent Vascular is headquartered in Wayne, PA.
-
What is the size of Cagent Vascular?
Cagent Vascular has 78 total employees.
-
What industry is Cagent Vascular in?
Cagent Vascular’s primary industry is Surgical Devices.
-
Is Cagent Vascular a private or public company?
Cagent Vascular is a Private company.
-
What is the current valuation of Cagent Vascular?
The current valuation of Cagent Vascular is .
-
What is Cagent Vascular’s current revenue?
The current revenue for Cagent Vascular is .
-
How much funding has Cagent Vascular raised over time?
Cagent Vascular has raised $118M.
-
Who are Cagent Vascular’s investors?
Astoria Health Investors, BF Belmont, Trinity Capital (Phoenix), Blue Ridge Medical., and The FSB Companies are 5 of 11 investors who have invested in Cagent Vascular.
-
Who are Cagent Vascular’s competitors?
Wallaby Medical, Mercator MedSystems, Arsenal Medical, Vesper Medical, and Elixir Medical are some of the 27 competitors of Cagent Vascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process